What is Entosystem?
Entosystem is at the forefront of agricultural innovation, specializing in insect farming technology to produce entomological proteins and flour. By valorizing food waste, the company not only contributes to a circular economy but also enhances food safety. Their cutting-edge approach positions them as a key player in sustainable agriculture and alternative protein sources.
How much funding has Entosystem raised?
Entosystem has raised a total of $58M across 1 funding round:
Other Financing Round
$58M
Other Financing Round (2024): $58M with participation from Fondaction, Sanimax, and Idealist Capital
Key Investors in Entosystem
Fondaction
Fondaction is a Quebec-based retirement savings fund that invests in companies to create and maintain quality jobs, contributing to a stronger, more equitable, and greener economy.
Sanimax
Sanimax is a BioReturn company specializing in rendering by-products into agriculture and animal nutrition products, offering a range of collection services and producing valuable ingredients from waste streams.
Idealist Capital
Idealist Capital is a growth-oriented private equity firm focused on empowering change agents and investing in entrepreneurs who innovate to reshape industries, particularly in enhancing efficiency and reducing waste.
What's next for Entosystem?
With this major enterprise-level funding, Entosystem is poised for significant scaling and further development of its insect farming operations. The strategic investment suggests a focus on expanding production capacity, enhancing technological capabilities, and potentially broadening market reach. This backing will likely accelerate their mission to create sustainable protein solutions and contribute to a more circular food system.
See full Entosystem company page
